This result suggests that anti-TB therapy tries to induce a balance of CD4+ T cell subpopulations, apparently through quantity, perhaps as a first effort to avoid an excessive inflammatory status, which is not beneficial for the host. This evidence concerns the gene CD4 and tuberculosis.